ay.ivaturi
Submits third-party assay reports on material purchased directly. Based in Rotterdam.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.98%
n=10
Suppliers covered
10
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043235 | Semax | SSA | SSA-2604-L8146 | Janoshik | 2026-Q2 | 98.89 | 8.38 | 98.1 | Supplier-supplied | 0 | PASS |
| AX-2026-041363 | Tirzepatide | WWB | WWB-2604-T3876 | Janoshik | 2026-Q2 | 98.98 | 3.90 | 97.9 | Buyer-sourced | 0 | PASS |
| AX-2026-041786 | BPC-157 | FGP | FGP-2601-E1919 | PeptideMeter | 2026-Q2 | 99.63 | 3.74 | 104.9 | Buyer-sourced | 0 | PASS |
| AX-2026-041930 | Semax | JEEP | JEEP-2512-U4819 | Janoshik | 2026-Q1 | 99.93 | 7.25 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020369 | GHRP-2 | MKM | MKM-2506-K3309 | Kestrel | 2025-Q4 | 98.84 | 3.45 | 99.4 | Buyer-sourced | 2 | FAIL |
| AX-2025-020516 | Tirzepatide | KP | KP-2504-V5439 | Medutest | 2025-Q3 | 98.98 | 4.90 | 99.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004828 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2408-P1394 | Janoshik | 2024-Q4 | 99.63 | 2.25 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004971 | Tirzepatide | ERP | ERP-2406-E7850 | Kestrel | 2024-Q3 | 98.69 | 4.01 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004322 | L-Glutathione (reduced) | QSC | QSC-2405-A5964 | Janoshik | 2024-Q3 | 99.77 | 6.12 | 99.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005380 | Semax | CPC | CPC-2309-M2265 | PeptideMeter | 2024-Q1 | 98.65 | 6.02 | — | Buyer-sourced | 1 | MARGINAL |